Ipilimumab/nivolumab-related steroid-refractory toxicities

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-019-69709-1
中图分类号
学科分类号
摘要
引用
收藏
页码:8 / 8
相关论文
共 50 条
  • [1] Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report
    Ammar B Nassri
    Valery Muenyi
    Ahmad AlKhasawneh
    Bruno De Souza Ribeiro
    James S Scolapio
    Miguel Malespin
    Silvio W de Melo Jr
    [J]. World Journal of Gastrointestinal Pharmacology and Therapeutics, 2019, (01) : 29 - 34
  • [2] Ipilimumab/Nivolumab-related orthostatic myoclonus in a patient with metastatic melanoma
    Green, B.
    Tse, W.
    [J]. MOVEMENT DISORDERS, 2023, 38 : S251 - S251
  • [6] Nivolumab-related mucous membrane pemphigoid
    Sibaud, Vincent
    Vigarios, Emmanuelle
    Siegfried, Aurore
    Bost, Chloe
    Meyer, Nicolas
    Pages-Laurent, Cecile
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 121 : 172 - 176
  • [7] Successful mycophenolate mofetil treatment of a patient with severe steroid-refractory hepatitis evoked by nivolumab plus ipilimumab treatment for relapsed bladder cancer
    Omori, Ginji
    Takada, Kohichi
    Murase, Kazuyuki
    Hayasaka, Naotaka
    Nakamura, Hajime
    Iyama, Satoshi
    Ohnuma, Hiroyuki
    Miyanishi, Koji
    Fukuta, Fumimasa
    Tanaka, Toshiaki
    Masumori, Naoya
    Kato, Junji
    [J]. CLINICAL CASE REPORTS, 2021, 9 (02): : 654 - 659
  • [10] Nivolumab Induced Steroid-Refractory Cold Agglutinin Disease Successfully Treated with Rituximab
    Hasanov, Merve
    Konoplev, Sergej
    Hernandez, Cristhiam Rojas
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S300 - S301